Stories

Discover all of the trending stories of Ipsen Group.

Explore more by category

Filter

Period

Filter by

recent search

Showing: 15 of 174 stories

Built to endure: Prince Korah on relentless pursuit of robust drug product development.
 • 2 mins read

 – 2 mins read

Built to endure: Prince Korah on relentless pursuit of robust drug product development.

Robustness is not a box to check—it’s the foundation of every decision. As a Senior Director in the Pharmaceutical Development function in Ipsen’s drug product development team, Prince Korah focuses on driving the pharmaceutical development strategy by overseeing the end-to-end life cycle of drug products with his team.


Ipsen Certified in 30 Countries: A New Milestone in Our Cultural Transformation 
 • 1 mins read

 – 1 mins read

Ipsen Certified in 30 Countries: A New Milestone in Our Cultural Transformation 

We’re proud to share that Ipsen has been certified as a Great Place to Work in 16 countries in 2025, bringing our total to 30 countries worldwide recognized as employers of choice. This achievement is a strong testament to our…


Ipsen’s Giving-Back Programs: Our Sustainability Commitments Go Beyond Environment
 • 2 mins read

 – 2 mins read

Ipsen’s Giving-Back Programs: Our Sustainability Commitments Go Beyond Environment

At Ipsen, we go beyond environmental responsibility to place societal impact at the heart of our actions. Through a range of Giving-Back Programs, the company aims to make a positive difference in the communities where we operate.


Get Men Talking: Ipsen Joins the Movember Movement for the Third Year
 • 1 mins read

 – 1 mins read

Get Men Talking: Ipsen Joins the Movember Movement for the Third Year

This Movember, Ipsen once again champions men’s health through our “Get Men Talking” podcast series — a heartfelt initiative encouraging open conversations about prostate cancer and wellbeing.


Targeting what cannot be seen: Lindsey Rodrigues on the complexity of epigenetics
 • 2 mins read

 – 2 mins read

Targeting what cannot be seen: Lindsey Rodrigues on the complexity of epigenetics

Targeting what cannot be seen: Lindsey Rodrigues on the complexity of epigenetics or mutated in a particular cancer. We have to ask, ‘do we have an understanding of how this gene works? Can we design a medicine to treat it or to target it?”’